Kim, M., Kim, T. H., Shin, D. Y., Lim, D. J., Kim, E. Y., Kim, W. B., . . . Kim, W. G. (2018). Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study. Thyroid.
Styl ChicagoKim, Mijin, et al. "Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study." Thyroid 2018.
Citace podle MLAKim, Mijin, et al. "Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study." Thyroid 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..